Evidence map›Paper›PMID 31909299›Full record

ArticleJACC. Basic to translational science2019

Associations of Interleukin-5 With Plaque Development and Cardiovascular Events.

Anki Knutsson, Harry Björkbacka, Pontus Dunér, Gunnar Engström, Christoph J Binder, Anna Hultgårdh Nilsson, Jan Nilsson

Open access · goldAbstract read
In one paragraph

Article in JACC. Basic to translational science, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 1 pooled it
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 1 synthesis or guideline pooled it, 32 citations in OpenAlex.

  1. Guideline
  2. Nanomaterials-Based Immunotherapy for Atherosclerosis.Small (Weinheim an der Bergstrasse, Germany) · 2026
    Review
  3. Anti-Inflammatory Interleukins in the Pathogenesis of Atherosclerosis.International journal of molecular sciences · 2026
    Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Review
  10. Review
  11. Emerging Anti-Inflammatory COPD Treatments: Potential Cardiovascular Impacts.International journal of chronic obstructive pulmonary disease · 2024
    Review
  12. Immune cell-mediated features of atherosclerosis.Frontiers in cardiovascular medicine · 2024
    Review
  13. Review
  14. Review
  15. Article
  16. Review
  17. Review
  18. Article
  19. Observational
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Anki KnutssonDepartment of Experimental Medical Science, Lund University, Lund, Sweden.
Harry BjörkbackaDepartment of Clinical Sciences Malmö, Lund University, Lund, Sweden.
Pontus DunérDepartment of Clinical Sciences Malmö, Lund University, Lund, Sweden.
Gunnar EngströmDepartment of Clinical Sciences Malmö, Lund University, Lund, Sweden.
Christoph J BinderDepartment of Laboratory Medicine, Medical University of Vienna, Vienna, Austria.
Anna Hultgårdh NilssonDepartment of Experimental Medical Science, Lund University, Lund, Sweden.
Jan NilssonDepartment of Clinical Sciences Malmö, Lund University, Lund, Sweden.
Lund University · SEMedical University of Vienna · AT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Experimental studies have suggested an atheroprotective role of interleukin (IL)-5 through the stimulation of natural immunoglobulin M antibody expression. In the present study we show that there are no associations between baseline levels of IL-5 and risk for development of coronary events or stroke during a 15.7 ± 6.3 years follow-up of 696 subjects randomly sampled from the Malmö Diet and Cancer study. However, presence of a plaque at the carotid bifurcation was associated with lower IL-5 and IL-5 deficiency resulted in increased plaque development at sites of oscillatory blood flow in

Indexed as

ApoE, apolipoprotein EatherosclerosisCVD, cardiovascular diseaseHR, hazard ratioIL-5, interleukin-5ILC2, type 2 innate lymphoid cellsinterleukin 5MACE, major adverse cardiac eventsmyocardial infarctionOR, odds ratiostroke

Identifiers

PMID31909299
PMCPMC6939009
OpenAlexW2985439294

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.